Immune globulin (Therapure Biopharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameImmune globulin (Therapure Biopharma)
Drug Alias NameIntravenous immunoglobulin - Therapure BiopharmaHuman immunoglobulin - Therapure BiopharmaTherapure PlasmaCap IGPlasmaCap IG10% intravenous immunoglobulin - Therapure Biopharma
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsImmunologic Deficiency SyndromesPrimary Immunodeficiency Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEvolve BiologicsTherapure Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesTherapure Biopharma IncEvolve Biologics
Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency Syndromes
Inactive IndicationsPrimary Immunodeficiency Diseases

Other Information

ATC CodeN/A
Related LinksN/A